Entresto 97 MG-103 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FWR75
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,059
Award facts
- Contract value 100% obligated
- $7,058.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) with a ceiling value of $7,058.93. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor under the DLA Troop Support Medical IDC, AmerisourceBergen supplies pharmaceutical products globally to support military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Entresto—a cardiac medication—reflects the company's role in supplying essential brand-name pharmaceuticals to federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FWR75?
SPE2DB25FWR75 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FWR75 worth?
The government has obligated $7,059 on SPE2DB25FWR75.
Is contract SPE2DB25FWR75 an order under another contract?
Yes. SPE2DB25FWR75 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWR75 competed?
The extent of competition for SPE2DB25FWR75 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award